Stay updated on Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPage revision updated to v3.5.2; the previous revision v3.5.0 has been removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedSite-wide update to version 3.5.0. The study details page content remains unchanged.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedThese are generic site maintenance updates and do not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check89 days agoChange DetectedA glossary feature was added to the page. In addition, several metadata labels and the revision information were updated, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' and the revision moved from v3.3.4 to v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.